FDA Sticks To Guns In Final Guidance On Production Changes
The U.S. Food and Drug Administration on Tuesday finalized guidance describing the types of low-risk drug manufacturing changes that only need to be reported annually, backing away from a few proposals...To view the full article, register now.
Already a subscriber? Click here to view full article